XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.1
1. Basis of Presentation and Use of Estimates Organization, Consolidation and Presentation of Financial Statements (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales $ 676,844 $ 700,062    
Cost of goods sold 314,427 297,427    
Deferred Revenue 75,300   $ 71,900  
Retained earnings 9,966,959   9,898,203  
Accumulated other comprehensive loss (408,352)   (466,822)  
Total stockholders' equity $ 9,763,716 $ 10,203,284 9,615,252 $ 13,685,236
Revenue Allocation Percent To Lease Elements 3.00% 2.00%    
Additional paid-in-capital $ 463,402   447,454  
Selling, general and administrative expense 225,553 $ 196,692    
Research and Development Expense 74,951 59,535    
Interest expense 12,337 4,048    
Other Nonoperating Income (Expense) 50,431 32,597    
Deferred Revenue, Current 56,900   $ 52,200  
Europe [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 204,800 218,900    
Asia Pacific [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 135,800 160,900    
UNITED STATES        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 297,000 282,500    
Americas [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales $ 39,200 $ 37,800